Related Experiment Video
Updated: Apr 6, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Assessing the optimal strategy for dual antiplatelet therapy
1a 1 Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Insights
Dual antiplatelet therapy after coronary stent placement balances preventing blood clots with the risk of bleeding. Individualized patient assessment is crucial for optimal treatment duration and outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Coronary artery disease (CAD) is a major global health concern, necessitating interventions like stent placement.
- Stent thrombosis is a significant risk, managed by dual antiplatelet therapy (DAPT) with aspirin and a thienopyridine for 6-12 months post-procedure.
- Emerging data highlight a trade-off with long-term DAPT: reduced ischemic events versus increased bleeding risk.
Discussion:
- The optimal duration of DAPT post-stent placement requires careful consideration of individual patient factors.
- Balancing the benefits of preventing ischemic events against the risks of bleeding is paramount.
- Personalized medicine approaches are essential for tailoring DAPT strategies.
Key Insights:
- Long-term DAPT (beyond 1 year) may prevent ischemic events in patients with coronary stents.
- Extended DAPT is associated with a higher incidence of bleeding complications.
- No one-size-fits-all approach exists; patient-specific risk-benefit analysis is critical.
Outlook:
- Future research should focus on identifying patient subgroups who benefit most from extended DAPT.
- Development of novel antiplatelet agents with improved safety profiles is warranted.
- Clinical guidelines need to evolve to incorporate individualized DAPT strategies for coronary stent recipients.
Abstract:
Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Each year, millions of patients undergo stent placement to treat coronary artery disease. As stents are prone to thrombosis, which can potentially be devastating, patients are treated with dual antiplatelet therapy with aspirin plus a thienopyridine for at least 6-12 months after stent placement. New evidence suggests that long-term dual antiplatelet therapy beyond 1 year prevents ischemic events but also leads to increased risk of bleeding. To determine the optimal strategy for dual antiplatelet therapy after stent placement, the benefits and risks must be carefully considered and individualized for each patient.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:26Atherosclerosis III: Management
01:29Venous Thrombosis III: Interprofessional Care
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...